Jump to content

Research to determine response

Recommended Posts

http://www.indystar.com/apps/pbcs.dll/a ... 7769606669

May 11, 2005

Lilly, Roche developing tests to match patients, cancer drugs

Indianapolis (Bloomberg) -- Roche Holding AG, the biggest maker of cancer drugs and diagnostic tests, will work with Indianapolis-based drugmaker Eli Lilly and Co. to develop tests to measure which patients will benefit from two cancer drugs.

The tests may help identify which patients are most likely to respond to Lilly's Alimta and Gemzar cancer drugs, said Switzerland-based Roche. The two companies will work with privately held Response Genetics Inc. on the "biomarker" tests.

"This agreement is excellent news for both physicians and patients as the world of truly personalized medicine becomes an ever-growing reality," said Heino von Prondzynski, head of Roche's diagnostic division, in an e-mailed statement.

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...

Important Information

By using this site, you agree to our Terms of Use.